Search Results
Site Search
Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D. - Insights
John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.
Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing...
Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC - Insights
Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases the risk for many...
Bobbi Pritt, M.D., Comments on Blacklegged Ticks in Minnesota Conservation Volunteer - Insights
Blacklegged ticks (also known as deer ticks) are turning up more frequently in Minnesota, and so are the diseases they carry. Bobbi Pritt, a parasitologist in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester,...
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D. - Insights
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.
MCL @Work: Brian Dukek - Insights
As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline...
MCL @Work: Jane Hermansen - Insights
Outreach manager Jane Hermansen regards Mayo Clinic as the pinnacle of healthcare. Having spent her formative years in Minnesota, she was inspired by her uncle Roger to embark on a path as a laboratory scientist. Presently, she oversees the...
High-Resolution Targeted Benzodiazepine Screen - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic’s targeted benzodiazepine assay and discusses the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine...
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.
Outreach Financial Management: The Basics and More - Insights
Skip to Content MayoACCESS MayoLINK...
Billing, Coding, and Payment Updates for 2023 - Insights
Skip to Content MayoACCESS MayoLINK...
Prostate Health Index (phi) [A Test in Focus] (Spanish) - Insights
https://www.youtube.com/watch?v=D5Q12Fk-J2Q
Skip to Content MayoACCESS MayoLINK...
Skip to Content MayoACCESS MayoLINK...
Podcasts
Research Roundup Archives - Page 29 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Leveraging the Laboratory 2023 Presentations - Insights
Skip to Content MayoACCESS MayoLINK...
Microbiology Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Answers From the Lab Archives - Page 18 of 27 - Insights
Skip to Content MayoACCESS MayoLINK...
MCL Whole Exome Sequencing Advanced Understanding of Genetic Disease Flyer MC2775523
MCL Exome Sequencing Advanced Understanding Genetic Disease Flyer EXOME SEQUENCING ADVANCED UNDERSTANDING GENETIC DISEASE millions individuals affected rare diseases 80
Education by MLS Credit Category - Insights
MLS CREDIT Online education and other offerings organized by Medical Laboratory Science credit categories.
Testing Archives - Page 6 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
September 2023 - Cardiovascular Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
Anti-hypertensive drug monitoring - Insights
Learn how Mayo Clinic Laboratories’ anti-hypertensive drug panel can assist physicians in understanding the reasons for resistant hypertension in patients.
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Neurodevelopmental disorders - Insights
Learn more about how chromosomal microarray can be used as a first-tier diagnostic test for those with congenital abnormalities and developmental disabilities.
Six ways innovative lupus tests are transforming patient and clinician experiences - Insights
The Lupus Foundation of America estimates that at least five million people worldwide have a form of lupus. Yet, the most widely used laboratory tests for patients with this complex condition were developed more than 60 years ago, and...
On Demand Education organized by MLS credit categories.
Invasive fungal infection - Insights
Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.
Histoplasma/Blastomyces - Insights
Mayo Clinic Laboratories full menu of testing for Histoplasma or Blastomyces infection includes an innovative, direct detection assay can detect antigens from both species.
Lab Medicine Rounds - Insights
A Mayo Clinic podcast for physicians, laboratory professionals, and students hosted by Justin Kreuter, M.D., (the Bow Tie Bandit of Blood) and featuring trending topics from subject-matter experts. Note: Podcasts will not play back on...
Mast cell activation syndrome - Insights
Learn more about how noninvasive urine mediator testing for mast cell activation syndrome available through Mayo Clinic Laboratories can provide clarity on disease presence and complement traditional diagnostic approaches.
Comprehensive urine drug profiles - Insights
Mayo Clinic Laboratories’ comprehensive controlled substance monitoring profiles use multiple methodologies to detect the lowest levels of substances.
Five trends happening in the laboratory industry - Insights
Managing a successful hospital-based laboratory in today’s economic climate requires leaders to anticipate challenges, navigate obstacles, and develop creative approaches to unusual circumstances. The Mayo Clinic Laboratories outreach team...
Mayo Clinic Laboratory and Pathology Research Roundup: January 16 - Insights
This week's research roundup feature: Understanding the incidence, causes, and trends of sudden cardiac death (SCD) among young competitive athletes is critical to inform preventive policies.
Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and...
Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D. - Insights
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune...
Pancreatic Elastase - Insights
Puanani Hopson, D.O., a Mayo Clinic pediatric gastroenterologist, explains the pancreatic elastase test — a screening test that can be useful when symptoms point to the possibility of exocrine pancreatic insufficiency. Dr. Hopson reviews...
SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) - Insights
Joseph Yao, M.D., explains how Mayo Clinic Laboratories’ SARS four-target test for viral respiratory disease can enhance patient care. The test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV....
Staphylococcus species assay [Test in Focus] - Insights
Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species. The assay is unique in its ability to distinguish the new organisms from Staphylococcus aureus, providing...
Managing patient expectations for home specimen collection - Insights
When patients are tasked with collecting specimens at home, the procedure can require special timing, collection steps, or storage conditions. If these aren’t clearly communicated to the patient beforehand, it can lead to confusion and...
Five Steps to Optimizing Your Outreach Test Menu - Insights
With changes in technology, medical practice, and market trends, and the expansion of health system services, the laboratory test menu can be ever in flux. It is essential that the laboratory test menu keeps up with trends, remaining...
Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' multigene panel helps identify the cause of hereditary ataxia. Precise diagnosis of this complex movement disorder helps guide patient treatment...
Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...
Neurofilament Light Chain (NFLC) - Insights
Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s...
Results report simplifies urine test interpretation: John Lieske, M.D. - Insights
John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones.
PCD test provides definitive diagnosis of a rare disease - Insights
Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D., explain how Mayo Clinic Laboratory can provide definitive diagnosis of primary ciliary dyskinesia (PCD). Mayo Clinic's expertise and technology have earned the laboratory's...
Cytomegalovirus, or CMV, is a common cause of disease in the transplant population. In some patients who are diagnosed with CMV and are on antiviral treatment for infections, the virus may develop resistance to the drugs. This “Hot Topic”...
Answers From the Lab Archives - Page 16 of 25 - Insights
Skip to Content MayoACCESS MayoLINK...
Hurricane Hilary: Potential specimen delays - Insights
Hurricane Hilary will be impacting the West Coast this weekend and into early next week. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Clients will be contacted directly by the couriers if...